A detailed history of Barclays PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Barclays PLC holds 50,000 shares of JNJ stock, worth $7.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Previous 5,723,116 99.13%
Holding current value
$7.75 Million
Previous $927 Million 99.13%
% of portfolio
0.0%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$145.48 - $167.38 $82.1 Million - $94.5 Million
564,681 Added 10.95%
5,723,116 $927 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $455 Million - $497 Million
-3,148,867 Reduced 37.9%
5,158,435 $754 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $99.1 Million - $104 Million
-638,239 Reduced 7.13%
8,307,302 $1.31 Billion
Q4 2023

Feb 15, 2024

SELL
$145.6 - $158.88 $341 Million - $372 Million
-2,341,936 Reduced 20.75%
8,945,541 $1.4 Billion
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $44,856 - $50,250
-288 Reduced -0.0%
11,287,477 $1.76 Billion
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $627 Million - $674 Million
4,059,112 Added 56.15%
11,287,765 $1.87 Billion
Q1 2023

May 04, 2023

SELL
$151.05 - $180.26 $603 Million - $720 Million
-3,995,221 Reduced 35.6%
7,228,653 $1.12 Billion
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $696 Million - $781 Million
4,344,809 Added 63.16%
11,223,874 $1.98 Billion
Q3 2022

Nov 03, 2022

BUY
$161.33 - $179.52 $333 Million - $371 Million
2,064,530 Added 42.88%
6,879,065 $1.12 Billion
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $291 Million - $322 Million
-1,731,717 Reduced 26.45%
4,814,535 $855 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $414 Million - $471 Million
-2,620,967 Reduced 28.59%
6,546,252 $1.16 Billion
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $129 Million - $143 Million
-827,471 Reduced 8.28%
9,167,219 $1.57 Billion
Q3 2021

Nov 09, 2021

BUY
$161.5 - $179.47 $558 Million - $620 Million
3,456,063 Added 52.86%
9,994,690 $1.61 Billion
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $237 Million - $254 Million
1,486,048 Added 29.41%
6,538,627 $1.08 Billion
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $115 Million - $129 Million
754,468 Added 17.55%
5,052,579 $830 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $85.5 Million - $98.1 Million
623,434 Added 16.97%
4,298,111 $676 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $88.2 Million - $96.6 Million
628,135 Added 20.62%
3,674,677 $547 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $52.4 Million - $63.3 Million
-407,082 Reduced 11.79%
3,046,542 $428 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $211 Million - $293 Million
-1,901,265 Reduced 35.51%
3,453,624 $453 Million
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $168 Million - $193 Million
-1,316,832 Reduced 19.74%
5,354,889 $781 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $66.6 Million - $74.5 Million
524,418 Added 8.53%
6,671,721 $863 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $138 Million - $151 Million
1,049,887 Added 20.6%
6,147,303 $856 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $69 Million - $76.7 Million
548,493 Added 12.06%
5,097,416 $713 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $69.9 Million - $84.1 Million
568,792 Added 14.29%
4,548,923 $587 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $6.61 Million - $7.76 Million
54,343 Added 1.38%
3,980,131 $550 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $113 Million - $125 Million
-946,389 Reduced 19.42%
3,925,788 $476 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $11.9 Million - $14.1 Million
95,272 Added 1.99%
4,872,177 $624 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $284 Million - $311 Million
2,162,028 Added 82.68%
4,776,905 $667 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $339 Million - $354 Million
2,614,877
2,614,877 $340 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.